Rules › DEA-2026-1321
Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V
Proposed rule from the Justice Department, Drug Enforcement Administration (docket DEA-2026-1321). 7 comment letters from companies and organizations are listed below.
- Agency
- Justice Department, Drug Enforcement Administration
- Docket
- DEA-2026-1321
- Published
- 2026-08-11
- Comments due
- 2026-09-10
- Status
- Comment period closed September 10, 2026 · no final rule found yet
- Total public comments
- 19
- Letters listed here
- 7
Federal Register notice ↗ · Docket on Regulations.gov ↗
Who commented, by industry
Pharma & Medical Devices 4 Other 2 Healthcare 1